全球血液凝固檢驗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

血液凝固檢驗市場預計將從 2025 年的 44.7 億美元成長到 2034 年的 78.9 億美元，2026 年至 2034 年的複合年成長率為 6.51%。

由於血液疾病發病率不斷上升以及對精準診斷檢測的需求日益成長，全球血液凝固檢驗市場正經歷穩定成長。血液凝固檢驗用於評估血液的正常凝血功能，對於診斷血友病、血栓症和肝病等疾病至關重要。醫院和診斷檢查室依靠這些檢測來後續觀察接受抗凝血治療或手術的患者。

診斷設備的科技進步正進一步推動市場成長。自動化凝血分析儀和就地檢驗設備提高了檢測效率，並使醫護人員能夠快速獲得檢測結果。手術數量的增加和抗凝血劑使用範圍的擴大也促進了對血液凝固檢驗服務需求的成長。

隨著醫療服務提供者致力於提高診斷準確性和病患監測，市場預計將持續擴張。對醫療基礎設施和檢測技術的投資增加將進一步推動市場成長。隨著人們對血液疾病和預防醫學的認知不斷提高，全球對可靠的血液凝固檢驗解決方案的需求預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球血液凝固檢驗市場：依產品類型分類

• 市場分析、洞察與預測
• 裝置
• 消耗品

第5章 全球血液凝固檢驗市場：依檢測類型分類

• 市場分析、洞察與預測
• 凝血酶原時間（PT）
• 活化部分凝血酶原凝血時間（APTT）
• 長號時間（TT）
• 活化凝血時間（ACT）
• 其他

第6章 全球血液凝固檢驗市場：依最終使用者分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷檢查室
• 居家醫療環境
• 其他

第7章 全球血液凝固檢驗市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers
  • Sysmex Corporation
  • Universal Biosensors Inc
  • HemoSonics LLC
  • Thermo Fisher Scientific Inc
  • Randox Laboratories Ltd
  • Horiba Ltd
  • Agappe Diagnostics Ltd
  • Medtronic Plc
  • Helena Laboratories Inc

The Coagulation Testing Market size is expected to reach USD 7.89 Billion in 2034 from USD 4.47 Billion (2025) growing at a CAGR of 6.51% during 2026-2034.

The global coagulation testing market is experiencing steady growth due to the increasing prevalence of blood-related disorders and the rising demand for accurate diagnostic testing. Coagulation tests are used to evaluate the blood's ability to clot properly and are essential for diagnosing conditions such as hemophilia, thrombosis, and liver disease. Hospitals and diagnostic laboratories rely on these tests to monitor patients undergoing anticoagulant therapy and surgical procedures.

Technological advancements in diagnostic equipment are further driving market growth. Automated coagulation analyzers and point-of-care testing devices are improving testing efficiency and delivering faster results for healthcare professionals. The growing number of surgical procedures and the increasing use of blood-thinning medications are also contributing to higher demand for coagulation testing services.

In the future, the market is expected to expand as healthcare providers focus on improving diagnostic accuracy and patient monitoring. Increasing investments in healthcare infrastructure and laboratory technologies will further support market growth. As awareness of blood disorders and preventive healthcare increases, the demand for reliable coagulation testing solutions will continue to rise globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Consumables

By Test Type

• Prothrombin Time (PT)
• Activated Partial Thromboplastin Clotting Time (APTT)
• Thrombin Time (TT)
• Activated Clotting Time (ACT)
• Others

By End-user

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Others

COMPANIES PROFILED

• F HoffmannLa Roche Ltd, Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, Universal Biosensors Inc, HemoSonics LLC, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Horiba Ltd, Agappe Diagnostics Ltd, Medtronic plc, Helena Laboratories Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COAGULATION TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COAGULATION TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Prothrombin Time (PT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Activated Partial Thromboplastin Clotting Time (APTT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Thrombin Time (TT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Activated Clotting Time (ACT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COAGULATION TESTING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COAGULATION TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL COAGULATION TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 F. Hoffmann-La Roche Ltd
  • 9.2.2 Abbott Laboratories
  • 9.2.3 Siemens Healthineers
  • 9.2.4 Sysmex Corporation
  • 9.2.5 Universal Biosensors Inc
  • 9.2.6 HemoSonics LLC
  • 9.2.7 Thermo Fisher Scientific Inc
  • 9.2.8 Randox Laboratories Ltd
  • 9.2.9 Horiba Ltd
  • 9.2.10 Agappe Diagnostics Ltd
  • 9.2.11 Medtronic Plc
  • 9.2.12 Helena Laboratories Inc